With either of those 2 treatments there will be refractory cases, people who do not respond especially where they are classed as "higher risk". That is where Ryoncil comes in.
When side effects are considered for at least one of those treatments reported on above, well that would be up to the specialists, patients and families as to the preferred treatment option.
Cell Therapy News/Articles, page-17810
-
- There are more pages in this discussion • 453 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
0.010(0.67%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $17.48M | 11.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 28835 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 120067 | 15 |
View Market Depth
| Last trade - 15.55pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |